Tag: pharmaceuticals
-
New Company Creating High-Capacity Gene Therapies to the Brain
A new business is underway developing gene therapies with higher capacities than most current technologies to treat neurodegenerative disorders.
-
Bone Regeneration Experiment Begun on Space Station
An experiment is underway testing a bone repair biomaterial in lab mice under weightless conditions on the International Space Station.
-
Trial Underway for Kidney Disease Microbiome Therapy
A clinical trial enrolled its first participant testing an engineered bacterial collection as a treatment for enteric hyperoxaluria, a kidney disorder with no approved cure.
-
Infographic – Higher HIV Burden for Women, Girls in Africa
The data show falling numbers of young men and women in sub-Saharan Africa with new HIV infections since 2010, but the percentage of infected women and girls also rising over that time.
-
Trial Shows Fast-Absorbing Opioid Overdose Nasal Swab
Results of a clinical trial show a nasal swab dispensing an opioid antidote transfers more of the antidote into the blood stream than syringe injections or nasal sprays.
-
Sustained-Released Eye Treatment Company Raises $11.9M
A company creating extended-release delivery techniques for eye therapies is raising $11.9 million in its first venture funding round.
-
Trial Shows Insulin Capsules Reduce Blood Glucose Levels
Results of a clinical trial reveal an optimal dose for an insulin capsule that in 12 weeks reduces blood glucose levels in patients with type 2 diabetes.
-
Biomarker-Guided Depression Drug Trial Underway
The first participant in a clinical trial received an experimental drug to treat patients with depression that express high levels of a stress-related protein.
-
Infographic – U.S. Dominates Diabetes Drug Sales
More than 133 million people have diabetes, nearly one-third of the world’s total, yet almost half of the world’s diabetes drug sales volume is in the U.S.
-
Biotech, Regeneron in $2B Cancer Antibody Deal
A developer of cancer treatments triggered by tumor chemistry is partnering with biologic drug maker Regeneron on dual-action cancer immunotherapies.